SCHEMBL5203052

SCHEMBL5203052

O=C(O)Oc1ccc(Br)c2c1OCO2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
KMT2A Q03164 5/20 0.36
MEN1 O00255 3/20 0.36
ALDH1A1 P00352 3/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35
AOC3 Q16853 1/20 0.34
CYP1A2 P05177 2/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
PKM P14618 2/20 0.31
CYP2D6 P10635 1/20 0.31
HPGD P15428 1/20 0.31
CYP2C19 P33261 1/20 0.31
TP53 P04637 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MAPT P10636 1/20 0.31
STAT1 P42224 1/20 0.30
ERN1 O75460 1/20 0.30
PREP P48147 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5200499 0.79 KDM4E (0.37) KDM4EALDH1A1LMNAHSD17B10MAPT
SCHEMBL6837756 0.76 ALDH1A1 (0.43) KDM4EKMT2AMEN1ALDH1A1LMNA
SCHEMBL5201408 0.74 TXNRD1 (0.45) KDM4EKMT2AMEN1ALDH1A1NPC1
SCHEMBL8951994 0.74 KDM4C (0.41) KDM4EALDH1A1LMNAHPGD
SCHEMBL4824144 0.73 SMN1; SMN2 (0.40) KDM4EKMT2AMEN1ALDH1A1LMNA
SCHEMBL31321811 0.70 AOC3 (0.38) KDM4EKMT2AMEN1ALDH1A1LMNA
SCHEMBL3828975 0.70 NCEH1 (0.37) ALDH1A1LMNACYP1A2NPC1RAB9A
SCHEMBL4823719 0.69 TARBP2 (0.41) KDM4EKMT2AALDH1A1LMNAHSD17B10
SCHEMBL28524665 0.68 ALDH1A1 (0.51) KDM4EALDH1A1LMNAHSD17B10AOC3
SCHEMBL15688428 0.67 AOC3 (0.37) AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1492771-B1 QUINOLINE AND ISOQUINOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS SCHERING AG (DE) 2007-02-28 EP disclosed